$TPHS
Trinity Place Holdings Inc. Stock $tphs

$tphs Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000155837022009007 Filed on May 16, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$6.359M	$7.554M	$24.45M
YoY Change	663.39%	1432.25%	9640.24%
Cost Of Revenue	$1.182M	$622.0K	$3.607M
YoY Change	-20.14%	-66.03%	32.51%
Gross Profit	$5.177M	$6.932M	$20.84M
YoY Change	-747.93%	-618.09%	-943.42%
Gross Profit Margin	81.41%	91.77%	85.25%
Selling, General & Admin	$1.503M	$1.139M	$837.0K
YoY Change	21.7%	-8.37%	-16.47%
% of Gross Profit	29.03%	16.43%	4.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$696.0K	$1.405M	$876.0K
YoY Change	71.85%	17.77%	17.43%
% of Gross Profit	13.44%	20.27%	4.2%
Operating Expenses	$8.649M	$9.195M	$24.15M
YoY Change	112.87%	117.02%	465.93%
Operating Profit	-$2.290M	-$1.641M	-$3.313M
YoY Change	-29.1%	-56.17%	-17.53%
Interest Expense	-$3.295M	-$802.0K	-$647.0K
YoY Change	273.16%	33.0%	-49.88%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$103.0K	-$2.468M	-$3.961M
YoY Change	-97.91%	-64.17%	-25.38%
Income Tax	$120.0K	$70.00K	$178.0K
% Of Pretax Income
Net Earnings	-$223.0K	-$2.538M	-$4.139M
YoY Change	-95.57%	-63.34%	-23.3%
Net Earnings / Revenue	-3.51%	-33.6%	-16.93%
Basic Earnings Per Share	-$0.01	-$0.07
Diluted Earnings Per Share	-$0.01	-$0.07	-$117.4K
COMMON SHARES
Basic Shares Outstanding	36.85M	37.10M	35.31M
Diluted Shares Outstanding	37.19M	37.10M

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.112M	$1.381M	$4.310M
YoY Change	43.48%	-72.57%	-33.84%
Cash & Equivalents	$3.100M	$1.400M	$4.310M
Short-Term Investments
Other Short-Term Assets	$1.639M	$1.659M	$673.0K
YoY Change	257.08%	108.94%	48.24%
Inventory
Prepaid Expenses
Receivables	$50.00K	$60.00K	$84.00K
Other Receivables	$121.0K	$118.0K	$114.0K
Total Short-Term Assets	$4.922M	$3.218M	$5.181M
YoY Change	70.9%	-53.02%	-35.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$67.15M	$290.5M	$291.0M
YoY Change	-77.71%	-0.09%	3.66%
Goodwill
YoY Change
Intangibles	$8.062M	$8.247M	$8.432M
YoY Change	-8.41%	-8.23%	-8.07%
Long-Term Investments	$4.600M	$4.700M	$4.800M
YoY Change	-9.8%	-9.62%	-15.79%
Other Assets	$228.0M	$14.23M	$20.54M
YoY Change	2890.27%	112.61%	114.94%
Total Long-Term Assets	$311.2M	$334.9M	$341.4M
YoY Change	-6.9%	3.37%	7.5%
TOTAL ASSETS
Total Short-Term Assets	$4.922M	$3.218M	$5.181M
Total Long-Term Assets	$311.2M	$334.9M	$341.4M
Total Assets	$316.1M	$338.1M	$346.6M
YoY Change	-6.24%	2.2%	6.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.82M	$19.88M	$17.86M
YoY Change	30.74%	38.34%	12.35%
Accrued Expenses	$1.245M	$1.347M	$1.447M
YoY Change	-18.95%	-17.16%	-15.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.07M	$21.22M	$19.31M
YoY Change	26.72%	32.69%	1025.35%
LONG-TERM LIABILITIES
Long-Term Debt	$246.9M	$262.5M	$270.7M
YoY Change	-5.89%	3.24%	11.49%
Other Long-Term Liabilities	$215.0K	$1.515M	$1.146M
YoY Change	-93.13%	-52.6%	38.07%
Total Long-Term Liabilities	$247.1M	$264.0M	$271.9M
YoY Change	-6.92%	2.55%	11.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.07M	$21.22M	$19.31M
Total Long-Term Liabilities	$247.1M	$264.0M	$271.9M
Total Liabilities	$271.2M	$285.2M	$291.2M
YoY Change	-4.67%	4.31%	11.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.55M	-$33.32M	-$30.79M
YoY Change	66.27%	66.97%	136.21%
Common Stock	$145.0M	$144.9M	$144.7M
YoY Change	6.07%	6.11%	6.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$57.46M	$57.46M	$57.17M
YoY Change	0.52%	0.52%	0.66%
Treasury Stock Shares	$6.541M	$6.551M	$6.398M
Shareholders Equity	$44.90M	$52.88M	$55.42M
YoY Change
Total Liabilities & Shareholders Equity	$316.1M	$338.1M	$346.6M
YoY Change	-6.24%	2.2%	6.44%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	-$223.0K	-$2.538M	-$4.139M
YoY Change	-95.57%	-63.34%	-23.3%
Depreciation, Depletion And Amortization	$696.0K	$1.405M	$876.0K
YoY Change	71.85%	17.77%	17.43%
Cash From Operating Activities	$989.0K	-$619.0K	-$5.880M
YoY Change	136.6%	-68.71%	72.59%
INVESTING ACTIVITIES
Capital Expenditures	$4.636M	-$4.704M	-$5.565M
YoY Change	-150.2%	-61.29%	-53.4%
Acquisitions
YoY Change
Other Investing Activities	$11.78M	$5.634M	$20.95M
YoY Change			303.45%
Cash From Investing Activities	$16.42M	$930.0K	$15.38M
YoY Change	-277.8%	-107.65%	-327.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$291.0K
YoY Change		-21.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.63M	-9.543M	2.694M
YoY Change	-341.59%	-197.49%	-66.59%
NET CHANGE
Cash From Operating Activities	989.0K	-619.0K	-5.880M
Cash From Investing Activities	16.42M	930.0K	15.38M
Cash From Financing Activities	-16.63M	-9.543M	2.694M
Net Change In Cash	778.0K	-9.232M	12.20M
YoY Change	-140.25%	112.67%	-682.15%
FREE CASH FLOW
Cash From Operating Activities	$989.0K	-$619.0K	-$5.880M
Capital Expenditures	$4.636M	-$4.704M	-$5.565M
Free Cash Flow	-$3.647M	$4.085M	-$315.0K
YoY Change	-137.78%	-59.85%	-103.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37104000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32591000
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000724742
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2022Q1	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32591000
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32694000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32643000
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32756000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32681000
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33322000
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2020Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2020Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2020Q4	tphs	Special Stock Value SpecialStockValue
CY2021Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q1	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q1	tphs	Special Stock Value SpecialStockValue
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q2	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q2	tphs	Special Stock Value SpecialStockValue
CY2022Q1	dei	City Area Code CityAreaCode	212
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2021Q3	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q3	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q3	tphs	Special Stock Value SpecialStockValue
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-08546
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	TRINITY PLACE HOLDINGS INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2465228
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	340 Madison Avenue
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10173
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	235-2190
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2022Q1	dei	Trading Symbol TradingSymbol	TPHS
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36850373
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	289300000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	289728000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1381000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14232000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5007000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4126000
CY2022Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18517000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	60000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	84000
CY2022Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	118000
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	114000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1224000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1314000
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8247000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8432000
CY2022Q1	us-gaap	Assets Assets	338086000
CY2021Q4	us-gaap	Assets Assets	346581000
CY2022Q1	us-gaap	Loans Payable LoansPayable	210768000
CY2021Q4	us-gaap	Loans Payable LoansPayable	219249000
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	33090000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	32844000
CY2022Q1	us-gaap	Secured Debt SecuredDebt	12750000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	12750000
CY2022Q1	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19876000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17864000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1347000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1515000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1146000
CY2022Q1	us-gaap	Liabilities Liabilities	285209000
CY2021Q4	us-gaap	Liabilities Liabilities	291163000
CY2022Q1	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43387563
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36836146
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	434000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	430000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144451000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144282000
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	6551447
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	57461000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1224000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1343000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33323000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30785000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	52877000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55418000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	338086000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346581000
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1260000
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	447000
CY2022Q1	us-gaap	Other Income OtherIncome	16000
CY2021Q1	us-gaap	Other Income OtherIncome	46000
CY2022Q1	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	6278000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	746000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	369000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1977000
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-802000
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-603000
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	402000
CY2022Q1	us-gaap	Revenues Revenues	7554000
CY2021Q1	us-gaap	Revenues Revenues	493000
CY2022Q1	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	548000
CY2021Q1	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1752000
CY2022Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	74000
CY2021Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1139000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1243000
CY2022Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	158000
CY2021Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	163000
CY2022Q1	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	6273000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1003000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	9195000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	4237000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1641000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3744000
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	193000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2468000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6889000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2538000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6924000
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2419000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6805000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37104000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32591000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55418000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2538000
CY2022Q1	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-291000
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	169000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	52877000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6924000
CY2021Q1	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1381000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5034000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14232000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6694000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15613000
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	57376000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2538000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-6924000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1405000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1193000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	123000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	133000
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	5000
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4000
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	12000
CY2022Q1	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-119000
CY2021Q1	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-119000
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	369000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1977000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	746000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2022Q1	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	168000
CY2021Q1	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	194000
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-24000
CY2021Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-47000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1008000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	371000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1474000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1294000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-619000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1978000
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	4704000
CY2021Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	12152000
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	5634000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	930000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12152000
CY2022Q1	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	2390000
CY2021Q1	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	8980000
CY2021Q1	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1200000
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	21000
CY2022Q1	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-11642000
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	291000
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9543000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9789000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9232000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4341000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15613000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	3050000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	4130000
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	66000
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	46000
CY2022Q1	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	9332000
CY2021Q1	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	7496000
CY2022Q1	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	617000
CY2021Q1	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	39000
CY2021Q1	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	760000
CY2022Q1	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	46000
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 – Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Trinity Place Holdings Inc., which we refer to in these financial statements as “Trinity,” “we,” “our,” or “us,” is a real estate holding, investment, development and asset management company. Our largest asset is currently a property located at 77 Greenwich Street in Lower Manhattan (“77 Greenwich”), which is nearing completion of development as a mixed-use project consisting of a 90-unit residential condominium tower, retail space and a New York City elementary school. We also own a recently built 105-unit, 12-story multi-family property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street in Brooklyn, New York (“237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), and, through joint ventures, a 50% interest in a recently built 95-unit multi-family property known as The Berkley, located at 223 North 8<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, Brooklyn, New York (“The Berkley”), see Note 14 – Subsequent Events, and a 10% interest in a recently built 234-unit multi-family property at 250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street (“250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), in Brooklyn, New York, and we own a property occupied by retail tenants in Paramus, New Jersey.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We also control a variety of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (“Syms”), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and An Educated Consumer is Our Best Customer® slogan. In addition, we had approximately $251.9 million of federal net operating loss carryforwards (“NOLs”) at March 31, 2022, which can be used to reduce our future taxable income and capital gains.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 Pandemic, Management’s Plans and Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As a result of the COVID-19 pandemic, numerous federal, state, local and foreign governmental authorities issued a range of “stay-at-home orders”, proclamations and directives aimed at minimizing the spread of COVID-19, among other restrictions on businesses and individuals. Additional proclamations and directives have been issued in response to further outbreaks, and may be issued in the future. The outbreak and restrictions have adversely affected our business operations including, among other things, a temporary suspension of construction work at our most significant asset, 77 Greenwich, which resumed in mid-April 2020, initially on a modified basis as certain work was deemed “essential” construction, and the temporary closing of the sales center for the 77 Greenwich residential condominium units as well as the temporary suspension of the remediation work being performed on 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>, which resumed in early June 2020 and was completed in the fourth quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The economic downturn and volatility in financial markets appear to have been primarily driven by uncertainties associated with the pandemic. As it relates to our business, these uncertainties include, but are not limited to, the adverse effect of the pandemic on the New York City and broader economy, residential and potential residential sentiment in New York City, particularly Manhattan, lending institutions, construction and material supply partners, travel and transportation services, our employees, residents and tenants, and traffic to and within geographic areas containing our real estate assets. The pandemic has adversely affected our near-term, and may adversely affect our long-term, liquidity, cash flows and revenues and has required and may continue to require significant actions in response, including, but not limited to, reducing or discounting prices for our residential condominium units more than originally budgeted, seeking loan extensions and covenant modifications, modifying, eliminating or deferring rent payments in the short term for tenants in an effort to mitigate financial hardships and seeking access to federal, state and/or local financing and other programs in 2020 and 2021. We were also subject to a New York State mandate disallowing tenant evictions for non-payment of rent due to COVID-19 related hardships throughout 2021, which was recently lifted on January 15, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The ultimate impact of the COVID-19 pandemic on our operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, recurring outbreaks, new information which may emerge concerning the pandemic and any additional preventative and protective actions that governments, lending institutions and other businesses, including us, may direct or institute. These and other developments have resulted in and are expected to result in an extended period of continued business disruption and reduced operations for us as well as for lending and other businesses and governmental entities with which we do business. The ultimate financial impacts cannot be reasonably estimated at this time but the outbreak, restrictions and future developments are anticipated to continue to have an adverse impact on our business, financial condition and results </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">of operations, which has been and may continue to be material, although in recent months we have seen indications of a recovery in the New York City real estate market and improvements in the financing markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The measures taken to date, together with any additional measures and developments including those noted above, impacted and will continue to impact the Company’s business in 2022 and beyond, although the extent of the significance of the impact of the COVID-19 outbreak on our business and the duration for which it may have an impact cannot be determined at this time. Although the impact of the pandemic has impeded the sale of residential condominium units at 77 Greenwich, we have closed on 17 residential condominium units as of March 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As of March 31, 2022, we had total cash and restricted cash of $15.6 million, of which approximately $1.4 million was cash and cash equivalents and approximately $14.2 million was restricted cash. At this time, we believe our existing balances of cash and cash equivalents, together with net proceeds that were generated from the sale of The Berkley, which closed in April 2022, planned refinancing of the Paramus line of credit or sale of the Paramus property and sales of the larger, higher floor condominium units at 77 Greenwich will be sufficient to satisfy our working capital needs and projected capital and other expenditures associated with our operations over the next 12 months, and the Company has concluded that management’s current plan alleviates the substantial doubt about its ability to continue as a going concern. Additionally, we continue to evaluate opportunities to raise capital through sales of equity, including under our ATM program, debt issuances or refinancings, including refinancing the property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, and continue to evaluate dispositions of other properties or other assets and/or sales of partial interests in properties. Facts and circumstances that are outside of management’s control could change in the future, such as additional government mandates, health official orders, travel restrictions and extended business shutdowns due to COVID-19, and the impact of such matters on residential sentiment in New York City in particular. </p>
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15600000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1400000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14200000
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">c. <i style="font-style:italic;">Use of Estimates</i> - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates.</p>
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">e. <i style="font-style:italic;">Concentrations of Credit Risk</i> - Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. We hold substantially all of our cash and cash equivalents in banks. Such cash balances at times exceed federally insured limits.</p>
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.31
CY2022Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	2700000
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	2900000
CY2022Q1	us-gaap	Development In Process DevelopmentInProcess	222595000
CY2021Q4	us-gaap	Development In Process DevelopmentInProcess	222394000
CY2022Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	51141000
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	51141000
CY2022Q1	us-gaap	Tenant Improvements TenantImprovements	221000
CY2021Q4	us-gaap	Tenant Improvements TenantImprovements	200000
CY2022Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	818000
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	775000
CY2022Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	28847000
CY2021Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	28847000
CY2022Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	303622000
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	303357000
CY2022Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	14322000
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	13629000
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	289300000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	289728000
CY2022Q1	us-gaap	Depreciation Depreciation	693000
CY2021Q1	us-gaap	Depreciation Depreciation	693000
CY2022Q1	tphs	Percentage Of Property Leased PercentageOfPropertyLeased	1
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11100000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11100000
CY2022Q1	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2900000
CY2021	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2700000
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	185000
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	185000
CY2022Q1	tphs	Aggregate Fees Paid By Sca To Company AggregateFeesPaidByScaToCompany	46100000
CY2022Q1	tphs	Remaining Fees To Be Paid By Sca To Company RemainingFeesToBePaidByScaToCompany	430000
CY2022Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	262471000
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3900000
CY2022Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1659000
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	673000
CY2022Q1	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2021Q4	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2022Q1	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2758000
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2736000
CY2022Q1	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	6601000
CY2021Q4	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	5593000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1594000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1467000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5007000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4126000
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3800000
CY2022Q1	tphs	Maximum Number Of Board Committees In Which Designee Can Sit MaximumNumberOfBoardCommitteesInWhichDesigneeCanSit	3
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	10064000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	193393000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	66021000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	269478000
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7007000
CY2022Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	4287000
CY2021Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	4990000
CY2022Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	3485000
CY2021Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	4387000
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-802000
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-603000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2019Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7179000
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.50
CY2021Q1	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	-2000000.0
CY2022Q1	tphs	Warrant Holder S Right Number Of Board Members To Appoint WarrantHolderSRightNumberOfBoardMembersToAppoint	1
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.31
CY2019Q4	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2019Q4	tphs	Warrant Agreement Threshold Maximum Percentage Of Issued And Outstanding Common Stock After Exercise Of Warrants WarrantAgreementThresholdMaximumPercentageOfIssuedAndOutstandingCommonStockAfterExerciseOfWarrants	0.199
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1500000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1100000
CY2022Q1	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	369000
CY2022Q1	tphs	Federal Net Operating Loss Carryforwards Utilized To Date FederalNetOperatingLossCarryforwardsUtilizedToDate	23800000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	67900000
CY2022Q1	tphs	Capital Stock Shares Authorized CapitalStockSharesAuthorized	120000000
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q1	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43387563
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36836146
CY2022Q1	tphs	Warrant Agreement Preemptive Rights Period WarrantAgreementPreemptiveRightsPeriod	P5Y
CY2022Q1	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2019Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000.0
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	250197
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	483361
CY2022Q1	tphs	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	1.93
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4500000
CY2022Q1	tphs	Special Stock Shares Authorized SpecialStockSharesAuthorized	1
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.59
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	598499
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.80
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	551083
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	548370
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	0
CY2022Q1	tphs	Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1500000
CY2021	tphs	Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized	0
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	25882
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.84
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	107754
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.77
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1195375
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	551083
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	469000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.43
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	333500
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.84
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	310000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.25
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	286084
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.20
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	227917
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2022Q1	tphs	Deferred Compensation Arrangement With Individual Shares Outstanding DeferredCompensationArrangementWithIndividualSharesOutstanding	310795
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	4700000
CY2022Q1	us-gaap	Derivative Assets DerivativeAssets	840000
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	198000
CY2020Q4	us-gaap	Liabilities Liabilities	261240000
CY2020Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38345540
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32172107
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	383000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2703000
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	19379000
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	966000
CY2020Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	90000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1565000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9172000
CY2020Q4	us-gaap	Assets Assets	325618000
CY2020Q4	us-gaap	Loans Payable LoansPayable	197330000
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	31858000
CY2020Q4	us-gaap	Secured Debt SecuredDebt	7747000
CY2020Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	15896000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1716000
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	830000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	746000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	275674000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	135978000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6173433
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	56791000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2159000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13033000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	325618000
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1563000
CY2020	us-gaap	Other Income OtherIncome	263000
CY2020	us-gaap	Revenues Revenues	1826000
CY2020	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	8590000
CY2020	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	254000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5217000
CY2020	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	345000
CY2020	us-gaap	Recapitalization Costs RecapitalizationCosts	133000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3907000
CY2020	us-gaap	Operating Expenses OperatingExpenses	18446000
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	7576000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2392000
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	84000
CY2020	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-1015000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1571000
CY2020	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	1110000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-190000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1571000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1540000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	261000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5169000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4863000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1015000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5878000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32305000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32860000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	57792000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4863000
CY2020	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-696000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-1015000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1163000
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	600000
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	359000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
CY2020	us-gaap	Profit Loss ProfitLoss	4863000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4168000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	806000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-686000
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1033000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10849000
CY2020	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	51282000
CY2020	tphs	Deferred Real Estate Deposits DeferredRealEstateDeposits	1971000
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	5383000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54694000
CY2020	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	86361000
CY2020	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	5000000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1497000
CY2020	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-23368000
CY2020	tphs	Repayment Of Loan And Secured Line Of Credit RepaymentOfLoanAndSecuredLineOfCredit	2500000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	695000
CY2020	tphs	Proceeds From Stock Buy Back ProceedsFromStockBuyBack	359000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62942000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2601000
CY2021Q1	us-gaap	Revenues Revenues	493000
CY2021Q1	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1752000
CY2021Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9196000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9474000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	15495000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	251000
CY2020	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	10319000
CY2020	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2727000
CY2020	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	356000
CY2020	tphs	Noncash Investment In Unconsolidated Joint Venture NoncashInvestmentInUnconsolidatedJointVenture	5193000
CY2021Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	285429000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5034000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6694000
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3343000
CY2021Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18814000
CY2021Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	919000
CY2021Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	102000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1478000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8987000
CY2021Q1	us-gaap	Assets Assets	330800000
CY2021Q1	us-gaap	Loans Payable LoansPayable	207317000
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	32104000
CY2021Q1	us-gaap	Secured Debt SecuredDebt	8950000
CY2021Q1	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14368000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1626000
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3196000
CY2021Q1	us-gaap	Liabilities Liabilities	273424000
CY2021Q1	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38840508
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32442633
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	388000
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136151000
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2040000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19957000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	57376000
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	330800000
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	447000
CY2021Q1	us-gaap	Other Income OtherIncome	46000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	4130000
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	46000
CY2021Q1	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	7496000
CY2021Q1	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	760000
CY2021Q1	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	39000
CY2021Q1	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1200000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1243000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2021Q1	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	194000
CY2021Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-47000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	371000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1294000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1978000
CY2021Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	12152000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12152000
CY2021Q1	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	8980000
CY2021Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	163000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	4237000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3744000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1977000
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-603000
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	193000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6889000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6924000
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6805000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32591000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6924000
CY2021Q1	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	57376000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-6924000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1193000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	133000
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	12000
CY2021Q1	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-119000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1977000
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	21000
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9789000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4341000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5034000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6694000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2934000
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1024000
CY2021Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18318000
CY2021Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	146000
CY2021Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	106000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1389000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8802000
CY2021Q2	us-gaap	Assets Assets	337121000
CY2021Q2	us-gaap	Other Income OtherIncome	256000
	us-gaap	Other Income OtherIncome	302000
CY2021Q2	us-gaap	Revenues Revenues	833000
CY2021Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	295631000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2169000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7626000
CY2021Q2	us-gaap	Loans Payable LoansPayable	215193000
CY2021Q2	us-gaap	Line Of Credit LineOfCredit	32351000
CY2021Q2	us-gaap	Secured Debt SecuredDebt	8950000
CY2021Q2	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17458000
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1536000
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3129000
CY2021Q2	us-gaap	Liabilities Liabilities	284480000
CY2021Q2	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38853433
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32455568
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	389000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136329000
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1922000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24989000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	52641000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337121000
CY2021Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	577000
	us-gaap	Revenues Revenues	1326000
CY2021Q2	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1549000
	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	3301000
CY2021Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	158000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1273000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2516000
CY2021Q2	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	162000
	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	325000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	4063000
	us-gaap	Operating Expenses OperatingExpenses	8300000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3230000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6974000
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-264000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1910000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-883000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1486000
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	623000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2816000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1910000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	816000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4933000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11822000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5032000
	us-gaap	Net Income Loss NetIncomeLoss	-11956000
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	118000
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	237000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4914000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11719000
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32694000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32643000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	57376000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5032000
CY2021Q2	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	1000
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-118000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	52641000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
	us-gaap	Net Income Loss NetIncomeLoss	-11956000
	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-369000
	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-237000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	351000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	52641000
	us-gaap	Profit Loss ProfitLoss	-11956000
	us-gaap	Share Based Compensation ShareBasedCompensation	265000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16000
	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-238000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	425000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-820000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	97000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3559000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1643000
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	21304000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21304000
	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	74486000
	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1200000
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2231000
	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-56413000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	369000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16673000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6274000
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	79000
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1411000
CY2021Q3	us-gaap	Liabilities Liabilities	295297000
CY2021Q3	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	110000
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1374000
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8617000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1516000
CY2021Q3	us-gaap	Assets Assets	347049000
CY2021Q3	us-gaap	Loans Payable LoansPayable	223503000
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	32597000
CY2021Q3	us-gaap	Secured Debt SecuredDebt	11950000
CY2021Q3	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	18457000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9795000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2169000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7626000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9795000
	us-gaap	Interest Paid Net InterestPaidNet	8564000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	49000
	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	8321000
	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	1629000
	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	85000
CY2021Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	302609000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	917000
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11732000
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3555000
CY2021Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18056000
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39016012
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32618137
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	390000
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136672000
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1803000
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26341000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	51752000
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	347049000
CY2021Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	967000
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1991000
CY2021Q3	us-gaap	Other Income OtherIncome	30000
	us-gaap	Other Income OtherIncome	332000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	87000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1352000
	us-gaap	Net Income Loss NetIncomeLoss	-13308000
CY2021Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	356000
CY2021Q3	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	1450000
	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	1450000
CY2021Q3	us-gaap	Revenues Revenues	2447000
	us-gaap	Revenues Revenues	3773000
CY2021Q3	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	805000
	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	4106000
CY2021Q3	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	76000
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	234000
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1255000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3771000
CY2021Q3	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	158000
	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	483000
CY2021Q3	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	1417000
	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	1417000
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1001000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3001000
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	4712000
	us-gaap	Operating Expenses OperatingExpenses	13012000
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2265000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9239000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1718000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	192000
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-692000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2178000
CY2021Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	160000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	976000
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1399000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13221000
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-47000
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1233000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12952000
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32756000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32681000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	52641000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1352000
CY2021Q3	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	166000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	51752000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
	us-gaap	Net Income Loss NetIncomeLoss	-13308000
	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-356000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	167000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	529000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	51752000
	us-gaap	Profit Loss ProfitLoss	-13308000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3977000
	us-gaap	Share Based Compensation ShareBasedCompensation	399000
	tphs	Gain Loss On Sale Of Residential Condominiums Net GainLossOnSaleOfResidentialCondominiumsNet	33000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20000
	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-356000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	192000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	686000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-887000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	846000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5775000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1542000
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	30666000
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	1328000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29338000
	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	82318000
	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	4200000
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2442000
	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-56413000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	167000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27460000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3420000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12649000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	917000
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11732000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12649000
	us-gaap	Interest Paid Net InterestPaidNet	13329000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	189000
	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	7101000
	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2406000
	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	130000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	289728000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4126000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	84000
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	114000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1314000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8432000
CY2021Q4	us-gaap	Assets Assets	346581000
CY2021Q4	us-gaap	Loans Payable LoansPayable	219249000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	32844000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	12750000
CY2021Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17864000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1146000
CY2021Q4	us-gaap	Liabilities Liabilities	291163000
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	430000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144282000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1343000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30785000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55418000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346581000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	3225000
CY2021	us-gaap	Other Income OtherIncome	355000
CY2021	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	24802000
CY2021	us-gaap	Revenues Revenues	28382000
CY2021	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	7785000
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	308000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4646000
CY2021	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	67000
CY2021	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	24432000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4003000
CY2021	us-gaap	Operating Expenses OperatingExpenses	41241000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-12859000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3012000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1134000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17487000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17752000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	816000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16936000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33322000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	64378000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17752000
CY2021	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-816000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7639000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	707000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55418000
CY2021	us-gaap	Profit Loss ProfitLoss	-17752000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5137000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	530000
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	321000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24000
CY2021	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-816000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000
CY2021	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	885000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-882000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	257000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3467000
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1288000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7443000
CY2021	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	36210000
CY2021	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	22275000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13935000
CY2021	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	249984000
CY2021	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	8200000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6552000
CY2021	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-225547000
CY2021	tphs	Repayment Of Loan And Secured Line Of Credit RepaymentOfLoanAndSecuredLineOfCredit	3200000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7639000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30154000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8776000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	16042000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	395000
CY2021	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	8805000
CY2021	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	3580000
CY2021	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	177000
CY2021	tphs	Loan Forgiveness Non Cash LoanForgivenessNonCash	243000

Files In Submission

Name	View Source	Status
0001558370-22-009007-index-headers.html	Edgar Link	pending
0001558370-22-009007-index.html	Edgar Link	pending
0001558370-22-009007.txt	Edgar Link	pending
0001558370-22-009007-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tphs-20220331.xsd	Edgar Link	pending
tphs-20220331x10q.htm	Edgar Link	pending
tphs-20220331x10q_htm.xml	Edgar Link	completed
tphs-20220331xex31d1.htm	Edgar Link	pending
tphs-20220331xex31d2.htm	Edgar Link	pending
tphs-20220331xex32d1.htm	Edgar Link	pending
tphs-20220331xex32d2.htm	Edgar Link	pending
tphs-20220331_cal.xml	Edgar Link	unprocessable
tphs-20220331_def.xml	Edgar Link	unprocessable
tphs-20220331_lab.xml	Edgar Link	unprocessable
tphs-20220331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TPHS
Trinity Place Holdings Inc. Stock $tphs

2022 Q2 Form 10-Q Financial Statement

#000155837022009007 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS Trinity Place Holdings Inc. Stock $tphs

2022 Q2 Form 10-Q Financial Statement

#000155837022009007 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS
Trinity Place Holdings Inc. Stock $tphs